Department of Clinical Biochemistry, Jagiellonian University Medical College, Kraków, Poland
Biography
Barbara Zapała currently works at the Department of Clinical Biochemistry, Jagiellonian University. Barbara does research in Neurology. Their most recent publication is 'A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 Diabetes Mellitus.
Skills and Expertise:Neurodegeneration,Neurobiology,Neurological Diseases,Brain Diseases,Mutation,Oncology,Diabetes,Epigenetics,Cancer,Neurodegenerative Diseases.
+44 1300 500008